These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature. Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880 [TBL] [Abstract][Full Text] [Related]
11. [Guillain-Barre syndrome associated with COVID-19]. Bogdanova AA; Kravtsunova ES; Raevskaia AI; Karpov AS; Gadaborshev RN; Dzutsev AI; Vyshlova IA; Karpov SM Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(9):132-136. PubMed ID: 36168699 [TBL] [Abstract][Full Text] [Related]
12. Guillain-Barré syndrome in the COVID-19 era: another occasional cluster? Tatu L; Nono S; Grácio S; Koçer S J Neurol; 2021 Apr; 268(4):1198-1200. PubMed ID: 32577868 [No Abstract] [Full Text] [Related]
13. A case report of Guillain-Barré syndrome in a pregnant woman infected by COVID-19. Mehrpour M; Arab M; Hadavand F; Khalafi M; Khalafi M Acta Neurol Belg; 2021 Aug; 121(4):1079-1080. PubMed ID: 34080170 [No Abstract] [Full Text] [Related]
14. Letter to the Editor: Finger Extensor Weakness Is Not a Novel Clinical Feature of SARS-CoV-2 Associated Guillain-Barre Syndrome. Finsterer J J Korean Med Sci; 2022 Jul; 37(27):e223. PubMed ID: 35818707 [No Abstract] [Full Text] [Related]
15. Guillain-Barré syndrome after SARS-CoV-2 infection. Kilinc D; van de Pasch S; Doets AY; Jacobs BC; van Vliet J; Garssen MPJ Eur J Neurol; 2020 Sep; 27(9):1757-1758. PubMed ID: 32533876 [No Abstract] [Full Text] [Related]
16. [SARS-CoV-2, a new causal agent of Guillain-Barre syndrome]. Redondo-Urda MJ; Rodríguez-Peguero FJ; Pérez-Gil O; Del Valle-Sánchez M; Carrera-Izquierdo M Rev Neurol; 2020 Oct; 71(7):275-276. PubMed ID: 32959360 [TBL] [Abstract][Full Text] [Related]